Christopher Wyatt, Ph.D., was born in Manchester, England. He received a bachelor's degree in pharmacology in 1991 from the University of Bath, UK, and a Ph.D. in neuropharmacology in 1994 from the University of Leeds, UK.
He worked as a postdoctoral research scientist at University College London, the University of Oxford and St Andrews University in Scotland. In 2007, he took an assistant professor position in the Department of Neuroscience, Cell Biology and Physiology (NCBP) at...
Jason Deibel, Ph.D. was promoted to Associate Professor in 2013. His research interests include ultrafast and terahertz spectroscopy and imaging, computational electromagnetics, and the characterization of novel materials. His work has been published in over 35 refereed journals and conference proceedings, and has been funded by the National Science Foundation, the Ohio Board of Regents, and the Air Force Research Laboratory as well as several private research and development companies. A...
Huntington's disease (HD) is a progressive and fatal genetic disorder characterized by severe motor and cognitive defects. The disease is caused by an expansion of CAG repeats in the Huntingtin gene. As a result, the disease symptoms are caused by some combination of the mutated huntingtin protein, toxic huntingtin RNA, and the extra glutamines encoded by the CAG repeats. Most studies of HD have focused on the central nervous system and the motor defects are widely considered to be the...
